Published : Jul-2018
No. of Pages : 185
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Tissue Sealants Overview 9
3 Products under Development 10
3.1 Tissue Sealants - Pipeline Products by Stage of Development 10
3.2 Tissue Sealants - Pipeline Products by Segment 11
3.3 Tissue Sealants - Pipeline Products by Territory 12
3.4 Tissue Sealants - Pipeline Products by Regulatory Path 13
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date 14
3.6 Tissue Sealants - Ongoing Clinical Trials 15
4 Tissue Sealants - Pipeline Products under Development by Companies 16
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development 16
4.2 Tissue Sealants - Pipeline Products by Stage of Development 18
5 Tissue Sealants Companies and Product Overview 20
5.1 Adhesys Medical GmbH Company Overview 20
5.2 Advanced Medical Solutions Group plc Company Overview 22
5.3 Aleo BME Inc Company Overview 23
5.4 Angiotech Pharmaceuticals Inc Company Overview 24
5.5 Baxter International Inc Company Overview 25
5.6 Biomedica Management Corp Company Overview 26
5.7 Boston University Company Overview 27
5.8 C. R. Bard Inc Company Overview 28
5.9 Calmare Therapeutics Inc Company Overview 30
5.10 Clemson University Company Overview 31
5.11 Cohera Medical Inc Company Overview 32
5.12 Covalent Medical, Inc. (Inactive) Company Overview 37
5.13 DSM Biomedical BV Company Overview 38
5.14 Elastagen Pty Ltd Company Overview 39
5.15 Ethicon Endo-Surgery Inc Company Overview 40
5.16 Gamma Therapeutics Inc Company Overview 41
5.17 GATT Technologies BV Company Overview 42
5.18 Gecko Biomedical Company Overview 44
5.19 Grifols SA Company Overview 45
5.20 Hemostasis LLC Company Overview 46
5.21 HyperBranch Medical Technology Inc Company Overview 47
5.22 Institute of Molecular Biology of Parana Company Overview 49
5.23 InVivo Therapeutics Corp Company Overview 50
5.24 Johns Hopkins University Company Overview 51
5.25 Kollodis BioSciences Inc Company Overview 52
5.26 Kuros Biosciences AG Company Overview 53
5.27 Laser Tissue Welding, Inc. Company Overview 55
5.28 LifeBond Ltd Company Overview 58
5.29 Medisse BV (Inactive) Company Overview 62
5.30 Pharming Group NV Company Overview 63
5.31 Polyganics BV Company Overview 64
5.32 Protein Polymer Technologies Inc (Inactive) Company Overview 67
5.33 Samyang Biopharmaceuticals Corp Company Overview 68
5.34 Sealantis Ltd. Company Overview 69
5.35 Shanghai Haohai Biological Technology Co Ltd Company Overview 71
5.36 Surgical Sealants, Inc. Company Overview 73
5.37 Teijin Pharma Ltd Company Overview 74
5.38 Texas A&M University Company Overview 75
5.39 The Medicines Company Overview 77
5.40 Tissue Regenix Ltd Company Overview 78
5.41 University of Akron Company Overview 79
6 Tissue Sealants- Recent Developments 80
6.1 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO 80
6.2 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 80
6.3 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 81
6.4 Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses 82
6.5 May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM 82
6.6 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends 83
6.7 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 84
6.8 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency 87
6.9 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference 87
6.10 May 14, 2018: Cesca Therapeutics Reports First Quarter 2018 Financial Results 89
6.11 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 90
6.12 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales 91
6.13 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 94
6.14 Apr 30, 2018: Kuros Biosciences Reports Full-Year 2017 Results 96
6.15 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018 96
6.16 Apr 25, 2018: Cohera Medical Awarded Patent on its Biodegradable Sealant Technology 98
6.17 Apr 25, 2018: The Medicines Company Reports First-Quarter 2018 Results 99
6.18 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 100
6.19 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 102
6.20 Mar 27, 2018: The Medicines Company Announces Chief Financial Officer Transition 103
6.21 Mar 22, 2018: Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update 104
6.22 Mar 20, 2018: LiDCO Group: End of third party UK Distribution agreement 105
6.23 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 106
6.24 Mar 14, 2018: Advanced Medical Solutions Group: Unaudited Preliminary Results for the year ended 31 December 2017 107
6.25 Mar 08, 2018: FDA Grants Breakthrough Device Designation to Polyganics' Liver and Pancreas Sealant Patch 114
6.26 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 115
6.27 Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors 116
6.28 Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results 116
6.29 Feb 01, 2018: Grunenthal Group receives FDA's Expedited Access Pathway designation for VIVO 118
6.30 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results 118
6.31 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 121
6.32 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 122
6.33 Jan 19, 2018: Grunenthal Group receives CE-Certification for innovative surgical sealant 124
6.34 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience 125
6.35 Jan 04, 2018: Sealantis Receives CE Marking For Seal-G Surgical Sealant For GI Procedures 126
7 Appendix 181
7.1 Methodology 181
7.2 About GlobalData 184
7.3 Contact Us 184
7.4 Disclaimer 184
1.1 List of Tables
Table 1: Tissue Sealants - Pipeline Products by Stage of Development 11
Table 2: Tissue Sealants - Pipeline Products by Segment 12
Table 3: Tissue Sealants - Pipeline Products by Territory 13
Table 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
Table 6: Tissue Sealants - Ongoing Clinical Trials 16
Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development 17
Table 8: Tissue Sealants - Pipeline Products by Stage of Development 19
Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
Table 10: CUTIS - Product Status 21
Table 11: CUTIS - Product Description 21
Table 12: VIVO - Product Status 22
Table 13: VIVO - Product Description 22
Table 14: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 15: Next Generation Internal Fixation And Sealant Device - Product Status 23
Table 16: Next Generation Internal Fixation And Sealant Device - Product Description 23
Table 17: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 18: Dural Sealant - Product Status 24
Table 19: Dural Sealant - Product Description 24
Table 20: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 21: Hemaseel HMN Fibrin Sealant - Product Status 25
Table 22: Hemaseel HMN Fibrin Sealant - Product Description 25
Table 23: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 24: Tisseel Dura - Product Status 26
Table 25: Tisseel Dura - Product Description 26
Table 26: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 27
Table 27: ClotBlock - Product Status 27
Table 28: ClotBlock - Product Description 27
Table 29: Boston University Pipeline Products & Ongoing Clinical Trials Overview 28
Table 30: Hydrogel-based Aerosolized Sealant Dressing - Product Status 28
Table 31: Hydrogel-based Aerosolized Sealant Dressing - Product Description 28
Table 32: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 33: Progel Dural Sealant - Product Status 29
Table 34: Progel Dural Sealant - Product Description 29
Table 35: Progel Emerald - Product Status 30
Table 36: Progel Emerald - Product Description 30
Table 37: Tridyne Peripheral - Product Status 30
Table 38: Tridyne Peripheral - Product Description 30
Table 39: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 40: Wound Sealant - Product Status 31
Table 41: Wound Sealant - Product Description 31
Table 42: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: Surgical Adhesive Hydrogel - Product Status 32
Table 44: Surgical Adhesive Hydrogel - Product Description 32
Table 45: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: Sylys Surgical Sealant - Product Status 33
Table 47: Sylys Surgical Sealant - Product Description 33
Table 48: Sylys Surgical Sealant - Drug Delivery - Product Status 34
Table 49: Sylys Surgical Sealant - Drug Delivery - Product Description 34
Table 50: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status 34
Table 51: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description 35
Table 52: Sylys Surgical Sealant - Orthopedic Procedures - Product Status 35
Table 53: Sylys Surgical Sealant - Orthopedic Procedures - Product Description 35
Table 54: Cohera Medical Inc - Ongoing Clinical Trials Overview 36
Table 55: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant 37
Table 56: Sylys Surgical Sealant - A Prospective, Randomized, Controlled, Multicenter Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant 37
Table 57: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
Table 58: Covabond - Product Status 38
Table 59: Covabond - Product Description 38
Table 60: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 39
Table 61: Dural Membrane Sealant - Product Status 39
Table 62: Dural Membrane Sealant - Product Description 39
Table 63: Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: MeTro - Surgical Glue - Product Status 40
Table 65: MeTro - Surgical Glue - Product Description 40
Table 66: Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 67: Bioseal Next Gen Device - Product Status 41
Table 68: Bioseal Next Gen Device - Product Description 41
Table 69: Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 70: GammaSeal - Product Status 42
Table 71: GammaSeal - Product Description 42
Table 72: GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview 43
Table 73: GATT-Spray - Product Status 43
Table 74: GATT-Spray - Product Description 43
Table 75: GATT-Tape - Product Status 44
Table 76: GATT-Tape - Product Description 44
Table 77: Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 45
Table 78: SETALUM Sealant - Product Status 45
Table 79: SETALUM Sealant - Product Description 45
Table 80: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 46
Table 81: Fibrin Biological Glue - Product Status 46
Table 82: Fibrin Biological Glue - Product Description 46
Table 83: Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 47
Table 84: Advanced Tissue Sealant - Product Status 47
Table 85: Advanced Tissue Sealant - Product Description 47
Table 86: HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 87: Adherus Vascular Sealant - Product Status 48
Table 88: Adherus Vascular Sealant - Product Description 48
Table 89: Tissue Plane Sealant - Product Status 49
Table 90: Tissue Plane Sealant - Product Description 49
Table 91: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 50
Table 92: Recombinant Fibrin Glue - Product Status 50
Table 93: Recombinant Fibrin Glue - Product Description 50
Table 94: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
Table 95: InVivoSeal - Product Status 51
Table 96: InVivoSeal - Product Description 51
Table 97: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 52
Table 98: Chondroitin Sulfate-based Adhesive - Product Status 52
Table 99: Chondroitin Sulfate-based Adhesive - Product Description 52
Table 100: Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 101: Hemostat Sealant - Product Status 53
Table 102: Hemostat Sealant - Product Description 53
Table 103: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 54
Table 104: KUR - 211 - Product Status 54
Table 105: KUR - 211 - Product Description 54
Table 106: KUR - 212 - Product Status 55
Table 107: KUR - 212 - Product Description 55
1.2 List of Figures
Figure 1: Tissue Sealants - Pipeline Products by Stage of Development 11
Figure 2: Tissue Sealants - Pipeline Products by Segment 12
Figure 3: Tissue Sealants - Pipeline Products by Territory 13
Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
Figure 6: Tissue Sealants - Ongoing Clinical Trials 16
